Test Price
2,800 AED✅ Home Collection Available
FBN1 Gene Stiff Skin Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FBN1 لمتلازمة الجلد المتصلب في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation by a DHA-licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – we confirm coverage before your draw.
- ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة بموجب ISO 15189 و ISO 9001:2015.
- اللوجستيات المتميزة: خدمة سحب عينات منزلية مدفوعة بمستوى المستشفيات عبر سلسلة تبريد معتمدة ونظام نقل معقم متقدم.
- الإرشاد السريري: استشارة هاتفية مجانية بعد الاختبار مع مستشار وراثي مرخص من هيئة الصحة بدبي.
- التأمين: التحقق المباشر من تغطية التأمين عبر الواتساب على الرقم +971 54 548 8731.
Comprehensive Test Overview
The FBN1 gene next‑generation sequencing (NGS) test identifies pathogenic variants linked to stiff skin syndrome, a rare congenital connective tissue disorder. This analysis reads the entire coding sequence with high coverage, providing definitive molecular confirmation for dermatologists and clinical geneticists.
| Feature | Our Test (Amref Health Africa – DHA/MOHAP Licensed) | Closest Alternative |
|---|---|---|
| Methodology | NGS (Next‑Generation Sequencing) – full coding region ±10 bp flanking intronic sequence; CNV detection included | Sanger sequencing of single exons or targeted mutation analysis only |
| Turnaround Time | 3 to 4 weeks (from sample arrival) | 6–8 weeks |
| Sample Types | Whole blood (EDTA), extracted DNA, or one drop of blood on an FTA card | Whole blood only |
| Regulatory Compliance | UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), UAE PDPL; ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Varies |
Physician Insight & Safety Protocol
“Stiff skin syndrome presents with progressive, rock‑hard skin thickening and joint contractures beginning in infancy. The FBN1 NGS test is the gold standard for molecular confirmation, but it must always be interpreted alongside clinical findings. Please do not alter any ongoing care or medication without speaking to your treating physician.”
— Dr. Prabhakar Reddy, DHA License 61713011, Senior Consultant Dermatology & Genetics
Medication Warning: Do not discontinue prescribed medication, including immunosuppressants or physiotherapy, without consulting your doctor. Genetic results require clinical correlation; they do not replace a rheumatology or dermatology follow‑up.
Exclusion Criteria & Emergency Red Flags
- Active unmanaged infection at the venepuncture site.
- Inability to provide informed consent (guardian required for minors under CDS Law 2026).
- Recent blood transfusion (within 2 weeks) – may interfere with DNA extraction.
- ER RED FLAGS: If you experience sudden joint dislocations, severe respiratory distress, or new skin ulcerations, proceed to the emergency department immediately; do not wait for genetic results.
Frequently Asked Questions
1. How accurate is the FBN1 NGS test for stiff skin syndrome?
Our NGS test delivers 99.9% diagnostic sensitivity for FBN1‑related stiff skin syndrome, capturing point mutations, small insertions/deletions, and exon‑level copy number changes. Because the assay covers all coding exons with at least 200× read depth, false negatives are extremely rare; a negative result in a clinically strong case may warrant whole‑genome sequencing or additional biochemical studies.
2. كم تستغرق نتيجة تحليل جين FBN1 لمتلازمة الجلد المتصلب؟
تصدر النتيجة خلال 3 إلى 4 أسابيع من وصول العينة إلى المختبر، مما يتيح بدء خطة العلاج دون تأخير طويل. قد يستغرق الإبلاغ عن المتغيرات الجديدة ذات الدلالة غير المؤكدة وقتاً إضافياً طفيفاً لإجراء التحليل المعلوماتي الإضافي والمراجعة السريرية.
3. Can the test be performed on a child younger than one year?
Yes, we routinely neonates and infants using a single drop of blood on an FTA card, a minimally invasive method that maintains DNA integrity during transport. Under UAE CDS Law 2026, written informed consent from the legal guardian is mandatory, and a paediatric genetic counselling session is scheduled before the collection.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians